|
|
 |
|
Viewing report
|
|
|
|
U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2010
iData Research, Nov 2009, Pages: 304
There are currently over 23.6 million people in the U.S., or almost 8% of the population who have diabetes. The diabetes market is expected to show substantial growth due to the obesity epidemic in the U.S., now becoming known as diabesity. This report covers the U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery, which includes
- blood glucose diagnosis and monitoring including traditional blood glucose monitors
- continuous glucose monitoring systems (CGM),
- blood glucose test strips
- lancets and lancing devices
This market also includes the markets for insulin and insulin delivery devices including syringes, pens, pumps and jet injectors as well as oral anti-diabetic drugs.
Over the forecast period, the U.S. market for diabetes drugs, devices and monitoring systems is expected to grow at double-digit rates, reaching a value of over $55 billion by 2016. The market for insulin will grow over 18% in 2009, while continuous glucose monitoring systems will see growth of 48%. This report provides a comprehensive analysis of the blood glucose monitoring, insulin delivery and antidiabetic drug markets.
Within the diabetic devices market, companies such as Abbott, Bayer, Eli Lilly, Lifescan, Medtronic and Roche lead the market. This report also covers the insulin market as well as oral and injectable antidiabetic drugs. Oral drugs are estimated to see double-digit growth through 2016, with companies such as Amylin, Bristol-Myers, Squibb, GlaxoSmithKline, Merck & Co., Novo Nordisk, Pfizer and Takeda leading the market. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Keywords:
blood glucose monitors, continuous glucose monitoring systems (CGM), blood glucose test strips, lancets and lancing devices, insulin, insulin pens, Oral anti-diabetic drugs, injectors
Customers who bought this item also bought
Diabetes Diagnostics - Global Strategic Business Report
Blood Glucose Meters And Strips - Global Strategic Business Report
The Future of the Diabetes Care Devices Market to 2016 - The Key Demand Drivers Remain Intact
The Future of the Diabetes Care Devices Market to 2016 -The Key Demand Drivers Remain Intact
Pipeline Insight: Insulin Antidiabetics - Novel analogs show promise as alternative delivery methods prove less attractive.
World Insulin Management Systems Market
France Diabetes Market Forecast 2011-2016
Saudi Arabia Diabetes Market Report & Forecast 2011-2016
Brazil Blood Glucose Monitoring Systems - Market Trends Till 2016
Brazil Diabetes Management Devices - Market Projections To 2016
|
|
|
|
